New ESC/EACTS Guidelines Enhance Management of Valvular Heart Disease
The ESC and EACTS have published updated guidelines for valvular heart disease, emphasizing minimally invasive treatment options, multidisciplinary care, and advanced imaging techniques to improve patient outcomes worldwide.
The European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) have released updated guidelines aimed at improving the diagnosis and treatment of valvular heart disease (VHD). Announced during the ESC Congress 2025, these guidelines incorporate the latest evidence from extensive research and large randomized controlled trials to promote the wider use of less invasive and innovative treatment options.
The revised recommendations were developed by an international panel led by Professor Fabien Praz, an interventional cardiologist at Bern University Hospital, and Professor Michael Borger, Director of Cardiac Surgery at the University of Leipzig, Germany. The guidelines emphasize the importance of shared decision-making and multidisciplinary Heart Teams, advocating that complex cases and procedures be managed at high-volume centers equipped with specialized expertise.
A key focus of the update is addressing the disparities in treatment across Europe. Professor Borger highlighted the variation in clinical practice, noting that patients with the same medical needs often receive differing treatments depending on their location. The new guidelines aim to standardize care and ensure that all patients have access to optimal treatment strategies.
Valvular heart disease affects millions worldwide, with aortic stenosis being the most common condition treated in developed countries. It is estimated to impact around 9 million people globally, while mitral regurgitation, the most prevalent type, affects approximately 24 million. The prevalence increases with age, predominantly affecting elderly patients with multiple comorbidities.
The guidelines provide detailed, practical recommendations to assist healthcare providers in making informed clinical decisions. They include updated insights on sex-specific considerations, accurate assessment of disease mechanisms, diagnostic protocols for complex cases, and the growing role of advanced imaging techniques such as 3D echocardiography, cardiac CT, and cardiac MRI.
Professor Praz emphasized that the rapid advancements in medical research have enhanced understanding and treatment of VHD, leading to better patient outcomes. He expressed hope that following these guidelines across Europe and beyond will improve care quality and consistency.
In summary, the 2025 ESC/EACTS guidelines serve as an essential resource for clinicians managing valvular heart disease. They promote timely interventions, equitable treatment access, and the integration of cutting-edge imaging technology, ultimately aiming for improved longevity and quality of life for patients.
Source: https://medicalxpress.com/news/2025-08-guideline-valvular-heart-disease.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Global Bioethics Training: Successes and Challenges in Building Ethical Research Capacity
A pioneering study highlights the achievements and hurdles in international bioethics training programs supported by NIH, emphasizing their importance in strengthening ethical research capacity in low- and middle-income countries.
Late-Life Mood Disorders as Early Indicators of Dementia
Emerging evidence suggests that mood disorders in older adults, such as depression and bipolar disorder, may be early signs of neurodegenerative diseases like dementia. Advanced brain imaging reveals tau protein accumulations years before cognitive decline, offering potential for early detection and intervention.
Strategies to Alleviate Primary Care Physician Burnout
Innovative approaches such as protected message handling time slots, team-based workflows, and recognizing gender differences are helping combat primary care doctor burnout caused by digital message overload. Discover how these strategies improve physician well-being and patient care.
New Research Shows Gabapentin May Extend Survival in Glioblastoma Patients
Emerging research suggests that gabapentin, a common nerve pain medication, may significantly extend survival in glioblastoma patients. A new study highlights the potential of repurposing existing drugs for cancer therapy, opening new avenues in brain cancer treatment.